US2005250102A1PendingUtilityA1
Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
Est. expiryApr 28, 2015(expired)· nominal 20-yr term from priority
C07K 16/3069A61P 35/04A61P 35/00C07K 14/70596C12Q 2600/112C12Q 1/6886G01N 33/575
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The isolation and characterization of a metastasis tumor suppressor gene KAI 1 is disclosed and diagnostic methods and gene therapy approaches utilizing reagents derived from the nucleotide and deduced amino acid sequences of the KAI 1 gene are provided.
Claims
exact text as granted — not AI-modified1 . A method for detecting the presence of malignant cancer in a subject comprising:
comparing KAI1 gene sequence, KAI1 mRNA or KAI1 protein of said subject to wild-type KAI1 gene sequence, mRNA or protein, an observed alteration of KAI1 gene sequence, KAI1 mRNA, or KAI1 protein of said subject as compared to wild-type indicating the presence of malignant cancer in said subject.
2 - 21 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.